4.9.3Segment

Contract Development & Manufacturing (CDMO)

Contract manufacturers producing API, drug products, biologics, and sterile injectables for pharmaceutical sponsors.

4
Verticals

Overview

Contract Development & Manufacturing (CDMO) covers contract manufacturers producing APIs, drug products, biologics, and sterile injectables for pharmaceutical sponsors. It is a fast-growing outsourcing market — Catalent (acquired by Novo Holdings), Lonza, Thermo Fisher, and Samsung Biologics among the leaders — driven by the outsourcing of complex manufacturing.

Demand is propelled by biologics and sterile-injectable growth, capacity constraints, and supply-chain-resilience concerns (including reshoring). It is capital-intensive and consolidating, with biologics and advanced-modality capacity the highest-value, most sought-after capabilities.

Market snapshot

FragmentationConsolidating

Within pharmaceutical manufacturing (NAICS 325412); CDMOs are not separately identified, so the segment is not separately sized by the Census Bureau.

Business model & economics

Revenue model
Development and manufacturing fees on contracted capacity
Recurring revenue
High — multi-year manufacturing contracts
EBITDA margin
20–30%
Capex intensity
High
  • Fast-growing outsourcing of complex manufacturing.
  • Biologics and sterile injectables drive demand.
  • Capacity, resilience, and reshoring concerns.

M&A deal context

High deal activity

Who’s acquiring

CDMO majors & strategicsPharma-services consolidatorsPE-backed manufacturing platforms

What’s driving deals

  • Acquisition of biologics and advanced-modality capacity.
  • Biologics and sterile-injectable demand.
  • Supply-chain resilience and reshoring.

Verticals in this segment

  • 4.9.3.1API & Drug Substance CDMOs

    Contract manufacturers producing active pharmaceutical ingredients.

  • 4.9.3.2Biologics & Cell/Gene Therapy CDMOs

    CDMOs manufacturing biologic drugs and advanced therapies.

  • 4.9.3.3Drug Product & Formulation CDMOs

    Contract manufacturers formulating finished solid and liquid dosage forms.

  • 4.9.3.4Sterile Injectable CDMOs

    CDMOs filling sterile liquid and lyophilized injectable products.

Find Contract Development & Manufacturing (CDMO) acquisition targets

Search Acquisera’s index for companies classified under Contract Development & Manufacturing (CDMO) (4.9.3) and build a targeted deal pipeline.

Search companies